Cardiac complications of checkpoint inhibitor therapy
Saturday 19 October 2019
9:30 - 10:30 CEST | 15:30 - 16:30 Beijing
Sign up here to be notified when this webcast is available online for viewing and CME credit.
Chair
Faculty
Overview
In this multidisciplinary webcast, global experts in cardiology and oncology will discuss the practical implications of new data on the cardiotoxicity of checkpoint inhibitors, using real-world cases to illustrate clinical pearls for the cardio-oncology service.
Learning objectives
Upon completion of this activity, participants will be better able to:
- Recognise the unique cardiotoxicity profile of immune checkpoint inhibitors
- Apply evidence-based strategies to the diagnosis and management of cardiotoxicity during and after treatment with checkpoint inhibitors
Registration
Registration is now closed.
Target audience
This activity is primarily intended for clinicians who have special interest in the cardiovascular needs of patients with cancer, including cardiologists, oncologists, nurses, and other members of the multidisciplinary cardio-oncology team.
Financial disclosures
Shanthini Crusz
Educational Travel Grant: Tesaro.
Javid Moslehi
Consultancy: Acceleron, Ariad, BMS, Daiichi-Sankyo, Deciphera, Heat Biologics, Incyte, Ipsen, Myokardia, Novartis, Pharmacyclics, Pfizer, Regeneron, Redux Therapeutics, Rgenix, StemCentRx, Takeda/Millennium, Vertex, Verastem.
Research grants: BMS, Pfizer.
Shares: Redux Therapeutics.
Jecko Thachil
Speaker’s Bureau: Bayer, Boehringer-Ingelheim, Daichii-Sankyo, Pfizer.
Jeroen Bax and Joe-elie Salem have no relevant financial relationships to disclose.
Staff at Siyemi Learning have no relevant financial relationships to disclose.
Continuing medical education
Siyemi Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Siyemi Learning designates this live activity for 1 AMA PRA Category 1 Credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
Commercial support
The ECOS 2019 meeting is supported by independent medical educational grants from Novartis and Bristol-Myers Squibb.
GE Healthcare provided in-kind support for the pre-conference workshop.
How to earn your CME credit
At the end of the live webcast you will be required to complete a short post-test, you will then be directed to the ECOS website where you will be able to complete the evaluation and download your CME certificate.
Please contact us at cme@cme-cpd.org with any questions or concerns.
Sign up here to be notified when this webcast is available online for viewing and CME credit.